Halozyme
HALO
168 hedge funds and large institutions have $1.09B invested in Halozyme in 2016 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 45 reducing their positions, and 17 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
85.51% more ownership
Funds ownership: 0% → 85.51% (+86%)
47% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 17
42% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 45
4% more funds holding
Funds holding: 162 → 168 (+6)
13% less capital invested
Capital invested by funds: $1.26B → $1.09B (-$161M)
23% less call options, than puts
Call options by funds: $14.2M | Put options by funds: $18.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$15.9M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$12.5M |
| 3 |
SAM
Senzar Asset Management
New York
|
+$7.39M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.28M |
| 5 |
State Street
Boston,
Massachusetts
|
+$6.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$13.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.4M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$4.17M |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$3.84M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$3.72M |
HALO Hedge Fund Activity: Q4 2016 in Review
168 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q4 2016, worth a combined $1.09B — down 13% from $1.26B a quarter earlier.
Buyers outnumbered sellers: 25 funds opened new HALO positions and 17 closed out — a net gain of 8 holders — while 64 added to existing stakes and 45 trimmed.
The largest buyer was Iridian Asset Management, adding an estimated $15.9M. The largest seller was Franklin Resources, cutting an estimated $13.1M.
- 168 institutional investors held Halozyme (HALO) as of Q4 2016, up from 162 in Q3 2016.
- Funds reported $1.09B of Halozyme stock for Q4 2016, down 13% quarter-over-quarter.
- 25 funds opened new Halozyme positions in Q4 2016 and 17 closed out, a net change of +8 holders.
- The largest Halozyme buyer in Q4 2016 was Iridian Asset Management, an estimated $15.9M added.
- The largest Halozyme seller in Q4 2016 was Franklin Resources, an estimated $13.1M sold.
Based on aggregated 13F filings for Q4 2016.